Skip to main content
. Author manuscript; available in PMC: 2015 Jan 22.
Published in final edited form as: Pharmacol Res. 2014 May 17;85:45–54. doi: 10.1016/j.phrs.2014.05.004

Figure 5.

Figure 5

Renal NADPH oxidase activity (A) and urinary TBARS excretion (B) in streptozotocin-induced diabetic mice. Renal NADPH oxidase activity and urinary TBARS excretion were significantly elevated in diabetic than control mice (*P <0.05 vs. control mice) but were reduced with ABT702 treatment (#P <0.05 vs. diabetic mice). However, urinary TBARS excretion remained significantly higher in diabetic mice treated with ABT702 compared with control (*P <0.05 vs. control mice, 7–8/group).